NADPH氧化酶4-衍生的过氧化平衡丸激素诱导的内皮功能障碍和迁移
Juliano V Alves1, Rafael M da Costa1,2,3,4,5, Wanessa M C Awata1
1Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
概括
高丸激素水平通过产生活性氧物种 (ROS) 来增加心血管风险. 这项研究揭示了NOX4作为一种保护性酶,平衡的作用.
科学领域:
- 心血管生物学 心血管生物学
- 内分泌学 在内分泌学.
- 氧化压力研究研究 氧化压力研究
背景情况:
- 高水平与通过反应性氧物种 (ROS) 生产的心血管疾病风险有关.
- 在心血管病理中,NADPH氧化酶 (NOX) 是关键的ROS来源.
- 在激素诱导的内皮损伤中,NOX4 (一种特定的ROS生成酶) 的作用尚不清楚.
研究的目的:
- 研究是否超生理水平诱导内皮NOX4表达以减轻内皮损伤.
- 阐明NOX4在调解高丸激素对心血管的影响中的作用.
主要方法:
- 人体内皮细胞 (HMEC,HUVEC) 用 (Testo) 和NOX4抑制剂或siRNA治疗.
- 在体内研究中,在雄性小鼠中给予丸激素,以评估内皮功能.
- 测量包括ROS产量,氧化 (NO) 水平和内皮细胞迁移.
主要成果:
- 丸激素增加了内皮细胞中的NOX4表达和活性.
- 激素诱导的ROS产生是由NOX1和NOX4抑制调节的.
- 丸激素损害了内皮功能和细胞迁移,因NOX4抑制而加剧的影响.
结论:
- 超生理丸激素水平上调内皮NOX4.
- NOX4作为一种补偿性保护机制,对激素诱导的内皮功能障碍起到作用.
- 在过氧化的形成中NOX4的作用对于平衡的有害血管效应至关重要.
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Testosterone: Functions and Regulation
640
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
640
Antihypertensive Drugs: Vasodilators
513
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
513
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Peroxisomes
12.1K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.1K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
148
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
148


